Fact-checked by Grok 2 weeks ago

Retinohypothalamic tract

The retinohypothalamic tract (RHT) is a that originates from intrinsically photosensitive retinal ganglion cells (ipRGCs) in the retina and projects directly to the (SCN) in the anterior hypothalamus, serving as the primary conduit for light information that entrains the body's central to the external day-night cycle.

Anatomy and Pathway

The RHT arises from a subset of ipRGCs, which constitute approximately 0.6–1% of total cells in sighted mammals and express the photopigment , enabling them to detect independently of and cones. These cells are distributed across the , with axons traveling through the , partially decussating at the , and terminating primarily in the ventral "core" region of the bilateral SCN, which contains about 10,000 neurons per side. Some RHT axons bifurcate to innervate adjacent structures, such as the intergeniculate leaflet (IGL) of the and the olivary pretectal (OPN), facilitating broader non-image-forming visual functions. The tract's pathway bypasses the of the visual , distinguishing it from image-forming visual projections.

Neurotransmitters and Signaling

RHT terminals primarily release glutamate as the excitatory , driving phase shifts in SCN neuronal activity in response to light pulses, while co-releasing pituitary adenylate cyclase-activating polypeptide (PACAP) as a neuromodulator that fine-tunes signaling via cAMP-dependent pathways, particularly during daytime light exposure. PACAP is expressed in small, type III/W cells and binds to PACAP-preferring receptors (PACAP-R1) densely localized in the ventral SCN, enhancing the tract's role in precise temporal adjustments without affecting nocturnal glutamatergic dominance. This dual-transmitter system allows the RHT to integrate both rapid excitatory responses and modulatory effects for robust photic input.

Physiological Functions

The RHT's core function is circadian photoentrainment, relaying environmental light cues to the SCN to synchronize endogenous rhythms with solar time, including sleep-wake cycles, hormone secretion (e.g., melatonin suppression during light exposure), and behavioral patterns like feeding. Light activation of the RHT during the early subjective night delays the circadian phase, while late-night exposure advances it, a process mediated by melanopsin phototransduction in ipRGCs. Beyond entrainment, the tract contributes to negative masking (suppression of activity by light), the pupillary light reflex, and acute alerting responses, underscoring its role in the non-image-forming visual system. Recent research has also identified endocannabinoid signaling in the RHT modulating orexin neuron activity in response to blue light, influencing sleep-wake regulation. In naturally blind mammals, such as the mole rat, the RHT persists with a higher proportion of melanopsin-expressing cells (up to 90% of RGCs), preserving circadian light sensitivity despite degenerate eyes. Disruptions to the RHT, as seen in optic nerve damage or melanopsin deficiencies, impair circadian alignment and related physiological processes.

Anatomy

Origin

The retinohypothalamic tract (RHT) originates from a specialized subset of retinal ganglion cells known as intrinsically photosensitive retinal ganglion cells (ipRGCs). These neurons express the photopigment , encoded by the OPN4 , which enables them to detect light directly without reliance on or cone photoreceptors. ipRGCs constitute approximately 0.2–2% of the total population across mammals, varying by species (e.g., ~0.5–1% in humans), and are primarily located in the ganglion cell layer of the . ipRGCs exhibit peak sensitivity to blue light at approximately 480 nm, allowing them to mediate non-image-forming visual functions through 's bistable properties. Unlike conventional ganglion cells, ipRGCs generate intrinsic photoresponses via activation, which depolarizes the cells through a G-protein-coupled signaling . Developmentally, ipRGCs emerge during embryogenesis, with extending into early postnatal stages in mammals. Their axons begin projecting to form the RHT early in , establishing to hypothalamic targets before the maturation of and cone pathways. This temporal precedence underscores ipRGCs' role as the initial photoreceptive elements in the embryonic .

Pathway

The retinohypothalamic tract (RHT) comprises axons that project directly from the to the (SCN) in a monosynaptic pathway, distinct from image-forming visual routes by bypassing the (LGN) of the . These axons exit the through the , forming a minor component of the overall projections. At the , RHT fibers partially decussate, providing bilateral input to the SCN with both ipsilateral and contralateral components. The fibers proceed along the optic tract while staying segregated from conventional retinofugal pathways destined for visual centers. They then leave the optic tract to penetrate the in a ventral position relative to the SCN. This pathway is evolutionarily conserved among mammals, though fiber density varies by species; in rats, for instance, the RHT includes about 1,000–2,000 axons, while in humans it is estimated at ~5,000–10,000.

Termination

The retinohypothalamic tract (RHT) primarily terminates within the (SCN) of the , the central circadian pacemaker. Dense arborizations characterize its projections, concentrating in the ventral core subregion of the SCN. Synaptic terminals of the RHT form bouton-like structures that contact dendritic branches of SCN neurons, targeting populations that include cells and those containing (VIP). The tract exhibits bilateral innervation of the SCN, with fibers arriving from both ipsilateral and contralateral retinal origins to establish symmetric structural connectivity. Secondary projections of the RHT extend to the intergeniculate leaflet (IGL) of the and provide sparse inputs to the olivary pretectal .

Neurochemistry

Glutamate

Glutamate serves as the primary fast-acting excitatory released from retinohypothalamic tract (RHT) terminals in response to photic , primarily from intrinsically photosensitive cells (ipRGCs).
This release occurs at synaptic contacts within the (SCN), where glutamate acts via ionotropic receptors to transmit light information essential for circadian regulation.
Glutamate is co-released with pituitary adenylate cyclase-activating polypeptide (PACAP) from these terminals.
Upon binding to AMPA/kainate and NMDA receptors on SCN neurons, glutamate triggers rapid and calcium influx, initiating downstream signaling cascades.
Among these, NMDA receptors play a critical role in facilitating light-induced phase shifts of the by promoting prolonged calcium-dependent changes in SCN cells.
This receptor-mediated excitation ensures precise to environmental light cues without relying on image-forming visual pathways.
The packaging and vesicular release of glutamate in ipRGC axons are mediated by the vesicular (VGLUT2), which loads glutamate into synaptic vesicles for efficient upon ipRGC .
Disruption of VGLUT2 in melanopsin-expressing ipRGCs impairs glutamate , leading to deficits in photoentrainment.
This transporter's expression confirms the glutamatergic identity of the RHT projection.
Glutamate release from RHT terminals exhibits dependence on intensity, scaling with the strength of photic input to modulate SCN activity proportionally.
activation in ipRGCs supports sustained glutamate release, enabling continuous signaling of levels over extended periods, in to the transient responses of / pathways.
This intensity-encoding property allows the RHT to convey graded for robust circadian .

PACAP

Pituitary adenylate cyclase-activating polypeptide (PACAP) serves as a co-transmitter in the retinohypothalamic tract (RHT), where it is co-localized and co-released with glutamate from the terminals of intrinsically photosensitive cells (ipRGCs). This co-release occurs specifically during light stimulation, enabling PACAP to act through PAC1 receptors on (SCN) neurons. PACAP binds to G-protein-coupled PAC1 receptors, which stimulate adenylate cyclase to elevate intracellular cyclic AMP () levels, thereby modulating downstream signaling pathways in SCN neurons. This mechanism enhances and refines glutamate-induced phase shifts in the circadian clock, particularly potentiating phase advances during late-night light exposure while having minimal effects on early-night phase delays. PACAP expression is restricted to a subset of ipRGCs, where it plays a critical role in dawn- and dusk-specific of circadian rhythms by conveying temporal information about and duration. In PACAP models, photoresponses are disrupted, with abolition of light-induced phase advances in the SCN despite intact melanopsin-based phototransduction, underscoring PACAP's necessity for proper dynamics. PACAP-containing fibers from ipRGCs project selectively to the core region of the SCN, where they form dense innervation patterns overlapping with retinorecipient zones. Notably, 80-90% of melanopsin-expressing ipRGCs co-express PACAP, ensuring coordinated delivery of photic signals to the circadian pacemaker.

Physiological Functions

Circadian Entrainment

The retinohypothalamic tract (RHT) serves as the primary pathway conveying photic information from intrinsically photosensitive retinal ganglion cells (ipRGCs) to the (SCN), resetting the SCN's approximately 24-hour molecular oscillator to synchronize endogenous circadian rhythms with the external 24-hour light-dark cycle. This entrainment occurs through daily phase adjustments, where light exposure at dawn induces phase advances and at dusk induces phase delays in the SCN clock, ensuring alignment of behavioral and physiological processes with environmental time cues. Light pulses administered during the subjective night trigger phase shifts in the via RHT-mediated signaling to the SCN, with the magnitude and direction of these shifts governed by the timing of light exposure relative to the organism's internal clock. These effects follow a (PRC), which exhibits maximal phase delays in the early subjective night and maximal phase advances in the late subjective night. The ipRGCs release glutamate and pituitary adenylate cyclase-activating polypeptide (PACAP) at RHT terminals to activate SCN neurons, initiating immediate-early (e.g., Per1 and Per2) that drives these phase adjustments. Following integration of RHT inputs, the SCN coordinates the of peripheral clocks throughout the body via direct neural projections through the and indirect humoral signals, such as rhythmic release from the , thereby maintaining systemic circadian coherence. In constant environmental conditions lacking light-dark cycles, disruption of the RHT—such as through lesions or of ipRGCs—results in free-running circadian rhythms that gradually desynchronize from the external zeitgebers, leading to internal temporal misalignment and loss of photo.

Non-Image-Forming Visual Responses

The retinohypothalamic tract (RHT), formed by axons of intrinsically photosensitive retinal ganglion cells (ipRGCs), plays a key role in mediating acute, non-image-forming responses to light that influence immediate physiological and behavioral adjustments, distinct from long-term circadian entrainment. These responses include rapid signaling to suppress production and modulate states, relying on the tract's projections from the to subcortical targets beyond the (SCN). A primary function of the RHT is the acute suppression of pineal synthesis in response to evening exposure, which helps maintain the timing of the nocturnal peak without inducing phase shifts in the . This suppression occurs rapidly upon detection by ipRGCs, inhibiting sympathetic innervation to the via hypothalamic relays, thereby preventing premature onset that could disrupt sleep architecture. Studies in humans and demonstrate that this response is maximally sensitive to short-wavelength around 480 nm, underscoring the melanopsin-based phototransduction in ipRGCs that drives the RHT signaling. The RHT contributes to the (PLR) through ipRGC projections to the olivary pretectal (OPN), enabling constriction independent of image-forming vision. These projections form a direct retinopretectal pathway that bypasses the dorsal , allowing sustained pupillary responses to steady light levels even in the absence of rod and input. In melanopsin-knockout mice, the PLR shows reduced amplitude and slower recovery, confirming the essential role of ipRGC-driven RHT-like signaling in this reflex. Beyond autonomic reflexes, the RHT supports light-induced and regulation through photic of the SCN, which in turn relays signals to arousal centers including the , thereby increasing noradrenergic activity to promote and alertness. This pathway enhances cognitive performance and suppresses during unexpected light exposure at night, with human studies showing that blue-enriched light activates these circuits to elevate subjective within minutes. Additionally, the RHT influences by modulating affective responses to , contributing to seasonal adaptations such as increased resilience to shorter winter days in humans. The RHT also mediates negative masking, the acute suppression of locomotor activity during the subjective night in response to , independent of circadian shifts. This function is preserved in blind individuals with intact ipRGCs and is disrupted by ipRGC , highlighting the tract's role in immediate behavioral responses. In , ablation of the RHT or ipRGCs eliminates light aversion behaviors, where animals normally avoid bright in open fields due to its aversive salience; post-ablation mice exhibit no such avoidance, highlighting the tract's role in innate negative phototaxis mediated by non-image-forming detection. This finding parallels seasonal adaptations, where intact RHT function supports behavioral adjustments to varying photoperiods, aiding in mood stability during periods of reduced daylight.

Clinical Significance

Associated Disorders

Dysfunction of the retinohypothalamic tract (RHT) is implicated in several neurological and circadian disorders, particularly those involving disrupted photic input to the (SCN). In blind individuals with intact intrinsically photosensitive ganglion cells (ipRGCs), the RHT can preserve non-image-forming visual responses, such as circadian photoentrainment and suppression, allowing partial maintenance of daily rhythms despite loss of image-forming vision. However, optic nerve damage that severs the RHT leads to complete loss of photic signaling, resulting in total circadian desynchrony and conditions like non-24-hour sleep-wake disorder, characterized by free-running rhythms drifting out of alignment with the 24-hour day. The RHT is also associated with delayed sleep phase syndrome (DSPS) and non-24-hour sleep-wake disorder, where impaired RHT signaling fails to properly entrain the circadian system to environmental light cues, leading to chronic delays in sleep onset and offset or progressive drift in sleep-wake cycles. In DSPS, heightened sensitivity to phase-delaying effects of evening light via the RHT may exacerbate the disorder, while in non-24-hour disorder, particularly among those with total blindness, absence of functional RHT input prevents synchronization, manifesting as irregular or drifting sleep patterns. In Alzheimer's disease, degeneration of the SCN disrupts RHT inputs, contributing to circadian rhythm fragmentation and exacerbating sundowning, a behavioral syndrome involving increased agitation, confusion, and aggression in the late afternoon and evening. Post-mortem studies reveal loss of melanopsin-expressing ipRGCs, which impairs RHT-mediated photic signaling to the SCN, while age-related decline in SCN neurons further compromises circadian regulation, with sundowning prevalence reaching 20-28% in affected patients. Retinal dystrophies such as Leber's congenital amaurosis (LCA) can impair ipRGC function through disruptions in the retinal pigment epithelium's retinoid cycle, leading to sleep disturbances and circadian misalignment due to weakened RHT projections. In LCA caused by mutations like those in , ipRGC photoreception is compromised, correlating with reports of sleep-wake irregularities, though some preservation of non-visual responses may occur in early stages.

Therapeutic Applications

Bright light therapy, particularly with blue-enriched light in the 460-480 nm range, activates the retinohypothalamic tract (RHT) to facilitate circadian entrainment in conditions such as and disorder. This approach involves exposure to intensities of 2,500-10,000 for 30-60 minutes, typically in the morning, which suppresses and advances the circadian phase via intrinsically photosensitive retinal ganglion cells (ipRGCs) projecting through the RHT to the (SCN). Clinical studies demonstrate that such timed exposure reduces and improves alertness, with efficacy enhanced by the short-wavelength light that maximally stimulates in ipRGCs. Emerging preclinical explores agonists and PACAP modulators to enhance RHT signaling, particularly in blind patients lacking functional photoreceptors but retaining ipRGCs. These agents aim to amplify non-image-forming visual responses, restoring circadian photoentrainment by directly activating phototransduction or modulating PACAP release from RHT terminals in the SCN. In animal models of degeneration, agonists have shown promise in phase-shifting circadian rhythms, while PACAP receptor modulators potentiate signaling in the RHT-SCN pathway, suggesting potential for clinical translation in disorders like non-24-hour sleep-wake rhythm. Chronopharmacology utilizes RHT-mediated circadian inputs to optimize timed , particularly for SCN-targeted in . Administering selective serotonin inhibitors (SSRIs) in the evening aligns with peak SCN sensitivity, enhancing efficacy by synchronizing molecular clocks in the SCN and improving mood stabilization through reinforced RHT-driven rhythms. This timing strategy reduces side effects and boosts therapeutic outcomes, as evidenced by studies showing up to % greater response rates with chronomodulated dosing compared to regimens. Gene therapy approaches focus on restoring ipRGC function in retinal diseases by using adeno-associated viral (AAV) vectors to express in surviving retinal cells. Subretinal delivery of human via AAV2 vectors in models of end-stage retinal degeneration, such as , leads to long-term (over 1 year) expression and partial restoration of pupillary light responses and circadian photoentrainment through the RHT. These therapies bypass photoreceptor loss by conferring light sensitivity to inner retinal neurons, offering a viable option for preserving non-visual functions in advanced retinal pathologies.

References

  1. [1]
    The Retinohypothalamic Tract (RHT) in Sighted and Naturally Blind ...
    The neuronal pathway transmitting light to the SCN is known as the retinohypothalamic tract (RHT) (Hannibal, 2002). Other NIF functions mediated by the RHT are ...
  2. [2]
    Neuroanatomy, Nucleus Suprachiasmatic - StatPearls - NCBI - NIH
    Its major tract is the retinohypothalamic tract originating from photosensitive ganglion cells of the retina. Efferent projections from the suprachiasmatic ...
  3. [3]
  4. [4]
    Melanopsin in cells of origin of the retinohypothalamic tract - PubMed
    Here we show that most retinal ganglion cells (RGCs) that project to the SCN express the photopigment melanopsin.
  5. [5]
    94233 - Gene ResultOPN4 opsin 4 [ (human)] - NCBI
    Aug 19, 2025 · This gene encodes a photoreceptive opsin protein that is expressed within the ganglion and amacrine cell layers of the retina.
  6. [6]
    Intrinsically Photosensitive Retinal Ganglion Cells
    The melanopsin-expressing RGCs are also distinguished from conventional RGCs by their expression of pituitary adenylyl cyclase-activating protein (PACAP), a ...
  7. [7]
    Human melanopsin forms a pigment maximally sensitive to blue ...
    In all such cases, peak sensitivity around 480 nm has been reported [7,28,29], and this is generally accepted to be an accurate reflection of the spectral ...
  8. [8]
    Melanopsin and the Intrinsically Photosensitive Retinal Ganglion Cells
    Oct 23, 2019 · IpRGCs capture light with a G-protein-coupled receptor called melanopsin, depolarize like photoreceptors of invertebrates such as Drosophila, ...
  9. [9]
    Impaired circadian photosensitivity in mice lacking glutamate ...
    The principal neurotransmitter of this projection is glutamate, and ipRGCs use the vesicular glutamate transporter 2 (VGLUT2) to package glutamate into synaptic ...
  10. [10]
    Development of melanopsin-based irradiance detecting circuitry
    Mar 18, 2011 · Specifically, ipRGC neurogenesis extends beyond that of other RGCs, and ipRGCs begin innervating the SCN at postnatal ages, unlike most RGCs ...
  11. [11]
    Melanopsin retinal ganglion cells mediate light-promoted brain ...
    Aug 18, 2022 · During development, melanopsin-expressing intrinsically photosensitive retinal ganglion cells (ipRGCs) become light sensitive much earlier ...
  12. [12]
    Physiologic Diversity and Development of Intrinsically ... - Cell Press
    Intrinsically photosensitive retinal ganglion cells (ipRGCs) mediate numerous nonvisual phenomena, including entrainment of the circadian clock to light ...<|separator|>
  13. [13]
  14. [14]
  15. [15]
    A retinohypothalamic projection in the rat - Wiley Online Library
    The retinohypothalamic tract in the rat appears to arise from the ganglion cells of the retina and to terminate on the smaller dendritic branches of the ...
  16. [16]
    Properties of VIP+ synapses in the suprachiasmatic nucleus ...
    Jun 1, 2016 · VIP+ neurons receive direct glutamatergic input from the retinohypothalamic tract, the specialized photosensitive neurons that transmit light ...
  17. [17]
    Retinohypothalamic Tract Synapses in the Rat Suprachiasmatic ...
    Retinohypothalamic Tract Synapses in the Rat Suprachiasmatic Nucleus Demonstrate Short-Term Synaptic Plasticity.Missing: human | Show results with:human
  18. [18]
    Architecture of retinal projections to the central circadian pacemaker
    May 9, 2016 · Our results provide a better understanding of how retinal neurons connect to the central circadian pacemaker to synchronize endogenous circadian clocks with ...
  19. [19]
    Retinohypothalamic Tract - an overview | ScienceDirect Topics
    Although the RHT sends its densest projection to the SCNvl, smaller numbers of RHT axons reach the SCNdm, SPZ, anterior hypothalamic area (AHA), retrochiasmatic ...
  20. [20]
    Retinal ganglion cell projections to the hamster suprachiasmatic ...
    Sep 3, 2003 · Bifurcating axons of retinal ganglion cells terminate in the hypothalamic suprachiasmatic nucleus and the intergeniculate leaflet of the ...
  21. [21]
    Central Projections of Melanopsin-Expressing Retinal Ganglion ...
    They send axons directly to the suprachiasmatic nucleus (SCN), intergeniculate leaflet (IGL), and olivary pretectal nucleus (OPN), thereby contributing to ...
  22. [22]
    and Postsynaptic Changes between the Retinohypothalamic Tract ...
    Nov 15, 2019 · The SCN synchronizes to the light-dark cycle through the retinohypothalamic tract (RHT). RHT axons release glutamate to activate AMPA-kainate ...<|control11|><|separator|>
  23. [23]
    Modulation of NMDA-Mediated Clock Resetting in the ... - Frontiers
    Light entrains the master circadian clock in the suprachiasmatic nucleus (SCN) predominantly through glutamatergic signaling via NMDA receptors.
  24. [24]
    Impaired circadian photosensitivity in mice lacking glutamate ...
    The principal neurotransmitter of this projection is glutamate, and ipRGCs use the vesicular glutamate transporter 2 (VGLUT2) to package glutamate into synaptic ...
  25. [25]
    A Retinal Ganglion Cell That Can Signal Irradiance Continuously for ...
    Aug 15, 2012 · Melanopsin is not required for sustained ipRGC responses to bright light. As shown in Figure 3B, bottom, ganglion-cell photoreceptors could ...A Novel Retinal Preparation... · The Iprgcs Can Continuously... · Melanopsin Is Not Required...
  26. [26]
    Pituitary Adenylate Cyclase-Activating Peptide (PACAP) - Frontiers
    Here we report rodent stimulus–response characteristics of PACAP release from the RHT, and map these to responses of the suprachiasmatic nucleus (SCN) in intact ...
  27. [27]
  28. [28]
  29. [29]
  30. [30]
  31. [31]
  32. [32]
  33. [33]
  34. [34]
    Comparative Neurology of Circadian Photoreception - Frontiers
    The neuronal pathway transmitting light to the SCN is known as the retinohypothalamic tract (RHT) (Hannibal, 2002). Other NIF functions mediated by the RHT are ...
  35. [35]
    Action Spectrum for Melatonin Regulation in Humans
    Aug 15, 2001 · In addition to entraining pineal rhythms, light exposure can acutely suppress melatonin secretion (Rollag and Niswender, 1976; Lewy et al., 1980) ...<|control11|><|separator|>
  36. [36]
    Central projections of intrinsically photosensitive retinal ganglion ...
    Two types of melanopsin retinal ganglion cell differentially innervate the hypothalamic suprachiasmatic nucleus and the olivary pretectal nucleus. Eur J ...
  37. [37]
    Evaluation of functional integrity of the retinohypothalamic tract in ...
    A subset of RGCs expressing the photopigment melanopsin regulates non-image-forming visual system (NIFVS) functions such as pupillary light reflex (PLR) and ...
  38. [38]
    Retinal light perception and biological rhythms: The role of light in ...
    ... arousal centers in the brainstem, such as the noradrenergic locus coeruleus (45). Activation of these pathways by light can directly antagonize sleep ...
  39. [39]
    Light as a Modulator of Non-Image-Forming Brain Functions ... - MDPI
    Light can have acute impacts on NIF functions including melatonin suppression, pupillary constriction, and stimulation of alertness and cognitive performance.
  40. [40]
    Light-aversion in mice depends on non-image-forming irradiance ...
    Light-aversion in mice depends on non-image-forming irradiance detection ... Study of mice with ablated melGCs could positively identify melGCs as part of ...
  41. [41]
    Melanopsin, photosensitive ganglion cells, and seasonal affective ...
    New studies have deepened our understanding of the retinohypothalamic tract, which translates environmental light received by the retina into neural signals ...Missing: adaptations | Show results with:adaptations
  42. [42]
    Increased sensitivity of the circadian system to light in delayed sleep ...
    Patients with delayed sleep–wake phase disorder (DSWPD) demonstrate greater sensitivity of the circadian system to the phase‐delaying effects of light.
  43. [43]
    Potential Pathways for Circadian Dysfunction and Sundowning ...
    The goal of this review is to highlight the potential output and input pathways of the circadian system that may underlie circadian dysfunction and behavioral ...
  44. [44]
    Melanopsin retinal ganglion cell loss in Alzheimer disease - PMC
    Melanopsin retinal ganglion cells (mRGCs) are photoreceptors driving circadian photoentrainment, and circadian dysfunction characterizes Alzheimer disease (AD).
  45. [45]
    Prolonged Inner Retinal Photoreception Depends on the Visual ...
    Apr 13, 2016 · Our findings further suggest that ipRGC function may be impaired in eye diseases involving disruptions ... Mutations in RPE65 cause Leber's ...Missing: disturbances | Show results with:disturbances
  46. [46]
    Sleep and circadian phenotype in people without cone-mediated ...
    Direct evidence for a functional preservation of melanopsin-mediated ipRGC function has also been found in other retinal conditions (e.g. Leber congenital ...
  47. [47]
    Illuminating Rationale and Uses for Light Therapy - PMC
    ... retinohypothalamic tract (RHT) directly to the SCN, the mammalian master ... Behavioral parameters improved following morning bright light therapy, yet sleep ...Light And Circadian... · Clinical Approach To The... · Disorders Responsive To...
  48. [48]
    Effects of light on human circadian rhythms, sleep and mood
    Aug 20, 2019 · ... retinohypothalamic tract (RHT) and ... Beauchamp MT, Lundgren JD (2016) A systematic review of bright light therapy for eating disorders.Photoreceptors In The Retina · Light Therapy In Practice · Light Therapy Devices
  49. [49]
    Low-intensity blue-enriched white light (750 lux) and standard bright ...
    Jan 28, 2011 · It influences the circadian system and is the most sensitive to light with a wavelength of about 480 nm (blue light) [9–11]. According to the ...
  50. [50]
    Melanopsin Is Expressed in PACAP-containing Retinal Ganglion ...
    Results: Melanopsin expression was found in a subpopulation of RGCs located in the ganglion cell layer and displaced in the inner nuclear cell layer.
  51. [51]
    Pituitary adenylyl cyclase-activating peptide: A pivotal modulator of ...
    PACAP is a significant component of the Glu-mediated light-entrainment pathway. When Glu activates the system, PACAP receptor-mediated processes can provide ...
  52. [52]
    Antidepressants and Circadian Rhythm: Exploring Their ...
    Nov 21, 2021 · Scientific evidence that circadian rhythms affect pharmacokinetics and pharmacodynamics has highlighted the importance of drug dosing-time.Missing: delivery | Show results with:delivery
  53. [53]
    The Impact of Circadian Rhythms on Medication Timing and Efficacy
    Nov 5, 2024 · This narrative review explores the optimal timing of medication administration to maximize efficacy and minimize side effects in the treatment of psychiatric ...
  54. [54]
    Long-term restoration of visual function in end-stage retinal ...
    Oct 2, 2017 · We assess subretinal delivery of human melanopsin using an adeno-associated viral vector to remaining retinal cells in a model of end-stage retinal ...